Cardiovascular Toxicity Prevention

Detecting and preventing the cardiovascular harm that can accompany cancer treatment.

Research Area Overview

Many cancer therapies, from anthracyclines to immune checkpoint inhibitors, carry a risk of cardiovascular toxicity. This research area focuses on identifying that risk early and intervening before lasting damage occurs, so patients can complete their cancer treatment safely and with confidence.

Cardiologist pointing at an echocardiogram of the heart's four chambers on a monitor

Early Detection

Cardiac imaging and surveillance to catch problems sooner

Risk Stratification

Identifying which patients are most at risk

Safer Protocols

Informing treatment decisions that protect the heart

Related Publications

Get in Touch

Interested in collaborating with us or learning more about our clinical and research program? We’d love to hear from you.